Weekly injectable extended‑release buprenorphine increased prenatal opioid abstinence and reduced serious maternal adverse events
An NIH‑supported randomized trial of 140 pregnant adults with opioid use disorder found that weekly injectable extended‑release buprenorphine produced higher…